GURUGRAM: While more than 100 per cent target was achieved by the Gurugram district administration for Covishield vaccinations, less than 33 per cent of the tar-get was achieved for Bharat Biotech's Covaxin vaccina-tions, which was approved despite not having finished the Phase-III Clinical Trials. There were only 32 health workers who turned up for Covaxin vaccinations that were being given at Rajiv Nagar, Chauma and Laxman Vihar. Moreover, those peo-ple who had come to get inoc-ulated came with a hope that will be provided with Cov-ishield vaccination.According to sources, some of the health workers voluntarily opted to not get inoculated after coming to know that the vaccine pro-vided to them was Covaxin and not Covishield.
If You Like This Story, Support NYOOOZ
Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.
Stay updated with all the Delhi Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.
